| Clinical features and outcomes of immune checkpoint inhibitor–associated AKI: A multicenter study FB Cortazar, ZA Kibbelaar, IG Glezerman, A Abudayyeh, O Mamlouk, ... Journal of the American Society of Nephrology 31 (2), 435-446, 2020 | 296 | 2020 |
| G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine N Murakami, T Yokomizo, T Okuno, T Shimizu Journal of Biological Chemistry 279 (41), 42484-42491, 2004 | 270 | 2004 |
| Acute kidney injury in patients treated with immune checkpoint inhibitors S Gupta, SAP Short, ME Sise, JM Prosek, SM Madhavan, MJ Soler, ... Journal for immunotherapy of cancer 9 (10), 2021 | 134 | 2021 |
| Severe acute interstitial nephritis after combination immune-checkpoint inhibitor therapy for metastatic melanoma N Murakami, TJ Borges, M Yamashita, LV Riella Clinical Kidney Journal 9 (3), 411-417, 2016 | 117 | 2016 |
| A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant N Murakami, P Mulvaney, M Danesh, A Abudayyeh, A Diab, ... Kidney International 100 (1), 196-205, 2021 | 116 | 2021 |
| Risk of Metabolic Complications in Kidney Transplantation After Conversion to mTOR Inhibitor: A Systematic Review and Meta‐Analysis N Murakami, LV Riella, T Funakoshi American Journal of Transplantation 14 (10), 2317-2327, 2014 | 116 | 2014 |
| Renal complications of immune checkpoint blockade N Murakami, S Motwani, LV Riella Current Problems in Cancer 41 (2), 100-110, 2017 | 111 | 2017 |
| Co-Inhibitory Pathways and Their Importance in Immune Regulation N Murakami, LV Riella Transplantation 98 (1), 3-14, 2014 | 99 | 2014 |
| Therapeutic advances in COVID-19 N Murakami, R Hayden, T Hills, H Al-Samkari, J Casey, L Del Sorbo, ... Nature Reviews Nephrology 19 (1), 38-52, 2023 | 97 | 2023 |
| Blocking IFNAR1 inhibits multiple myeloma–driven Treg expansion and immunosuppression Y Kawano, O Zavidij, J Park, M Moschetta, K Kokubun, TH Mouhieddine, ... The Journal of clinical investigation 128 (6), 2487-2499, 2018 | 95 | 2018 |
| Sepsis pathophysiology and anesthetic consideration K Yuki, N Murakami Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current …, 2015 | 62 | 2015 |
| IgA Nephropathy after Nivolumab Therapy for Postoperative Recurrence of Lung Squamous Cell Carcinoma S Kishi, M Minato, A Saijo, N Murakami, M Tamaki, M Matsuura, ... Internal Medicine 57 (9), 1259-1263, 2018 | 61 | 2018 |
| Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes RLA Santos, L Bai, PK Singh, N Murakami, H Fan, W Zhan, Y Zhu, X Jiang, ... Nature communications 8 (1), 1692, 2017 | 54 | 2017 |
| Disaster preparedness and awareness of patients on hemodialysis after Hurricane Sandy N Murakami, HB Siktel, D Lucido, JF Winchester, NB Harbord Clinical Journal of the American Society of Nephrology 10 (8), 1389-1396, 2015 | 46 | 2015 |
| Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study M Grafals, B Smith, N Murakami, A Trabucco, K Hamill, E Marangos, ... PLoS One 9 (8), e104408, 2014 | 45 | 2014 |
| Notch-1 Inhibition Promotes Immune Regulation in Transplantation Via Regulatory T Cell–Dependent Mechanisms CN Magee, N Murakami, TJ Borges, T Shimizu, K Safa, S Ohori, S Cai, ... Circulation 140 (10), 846-863, 2019 | 35 | 2019 |
| Transplant Oncology: An Evolving Field in Cancer Care M Abdelrahim, A Esmail, A Abudayyeh, N Murakami, A Saharia, ... Cancers 13 (19), 4911, 2021 | 30 | 2021 |
| Codominant Role of Interferon‐γ–and Interleukin‐17–Producing T Cells During Rejection in Full Facial Transplant Recipients TJ Borges, JT O'Malley, L Wo, N Murakami, B Smith, J Azzi, S Tripathi, ... American Journal of Transplantation 16 (7), 2158-2171, 2016 | 30 | 2016 |
| Longitudinal immunological characterization of the first presensitized recipient of a face transplant TS Win, N Murakami, TJ Borges, A Chandraker, G Murphy, C Lian, ... JCI insight 2 (13), 2017 | 23 | 2017 |
| Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View M Abdelrahim, A Esmail, A Saharia, A Abudayyeh, N Abdel-Wahab, ... Cancers 14 (7), 1760, 2022 | 22 | 2022 |
